It is our great pleasure to announce the "1st Biotechnology World Congress" (1st BWC 2012)
to be held in Dubai, UAE, from February 14th-15th, 2012. The 1st BWC
2012 will highlight cutting-edge advances in all major disciplines of
Biotechnology. This two-day event will feature recent findings from
leading industrial, clinical and academic experts in the field, in the
form of lectures and posters. The 1st BWC 2012 will be unique in
promoting the translational nature of modern biotechnological research,
with emphasis on both the basic science in industry and academia as well
as its practical and clinical applications. Presentations would focus
on business development, strategic alliances, partnering trends, product
opportunities, growth business models and strategies, licensing and
pharmaceutical biotechnology, vaccines, CNS, cancer, antibodies, protein
engineering, plant and environmental technologies, transgenic plant and
crops, bioremediation, microbial diversity research.
A number of Nobel Laureates will deliver keynote lectures at the conference. The conference plans to bring together leading biotechnologists to discuss and present the latest important developments in biotechnology and allied disciplines. The 1st BWC 2012 will also provide a forum for in-depth assessment of the challenges involved in the dynamic and fast moving fields of biotechnology.
The details of the conference can be viewed at http://eureka-mkt03.com/conference/bwc
A number of Nobel Laureates will deliver keynote lectures at the conference. The conference plans to bring together leading biotechnologists to discuss and present the latest important developments in biotechnology and allied disciplines. The 1st BWC 2012 will also provide a forum for in-depth assessment of the challenges involved in the dynamic and fast moving fields of biotechnology.
The details of the conference can be viewed at http://eureka-mkt03.com/conference/bwc
This is an incredible opportunity to showcase your basic research, findings and practices in the various thematic sessions stated below.
The conference offers the following sessions in biotechnology:
1. Pharmaceutical Biotechnology: biopharmaceuticals discovery (CNS, cancer, cardiovascular, endocrine, immune); vaccines; antibodies; protein engineering
2. Plant and Environmental: transgenic plants and crops; bioremediation; microbial diversity; bio-monitoring.
3. Industrial and Manufacturing: bio-fuels; energy crops (cellulosic ethanol industry); industrial enzymes; bioprocess engineering and optimization.
4. Medical Biotechnology: stem cells; gene therapy; tissue engineering; biopharmaceutical manufacturing; cell based therapy; cell cultivation; diagnostics; imaging; pharmacogenomics (personalized medicine); microarray technology; biomarkers.
5. Business development: strategic alliances; partnering trends; product opportunities; growth; business models and strategies; licensing; merger and acquisitions; outsourcing; venture capital and financing; intellectual property.
6. Other areas: Food; Marine; Bio-safety; Systems Biology, Clinical Research/clinical trials; bioethics; nanobiotechnology.
No comments:
Post a Comment